Skip to main content

AWS HealthOmics customers

Caris Life Sciences

        “Caris Life Sciences is transforming cancer care by combining
        our precision medicine expertise with the secure, scalable
        workflows from AWS HealthOmics. With these capabilities,
        we’re unlocking new possibilities in data-driven oncology to
        deliver faster, more innovative, and more personalized
        patient solutions.”

David Spetzler, President, Caris Life Sciences

Missing alt text value

Inocras

        “Inocras's genomic analysis system infrastructure has
        evolved through three major phases: On-premises, Cloud
        migration, and Cloud native. The volume of incoming orders
        exceeded our expectations, resulting in demands for
        computing power and storage that surpassed our internal
        projections. With HealthOmics, infrastructure is
        implemented according to the computing resources defined
        in the workflow without building infrastructure in advance.”

Dawoon Jung, Solutions Architect and DevOps, Inocras

Read the blog

Missing alt text value

Phytoform Labs

        "Climate change isn't giving agriculture the luxury of time.
        While we could develop resilient traits through conventional
        breeding, it might take decades we don't have. We need to
        process thousands of multimodal omics experiments,
        something that would have been impossible with our
        on-premises infrastructure. AWS HealthOmics transformed
        how we approach bioinformatics at scale. We can deploy our
        customized nf-core pipelines across thousands of datasets
        while the service handles all the resource scaling and       
        parallelization automatically.”

David Spetzler, President, Caris Life Sciences
Dr. Nicolas Kral, CTO and Co-founder, Phytoform Labs

Read the blog

Missing alt text value

Amgen

"Using AWS HealthOmics, we can further our understanding of biology, target, and disease, ultimately informing decisions in Research and Development. For a company of Amgen’s size, having everything in one place is tremendous for reproducibility, transparency, security, and permissions."

Ittai Eres, Senior Scientist in Bioinformatics Technologies, Center for Research Acceleration by Digital Innovation, Amgen
Missing alt text value

Roche

        "Our bioinformaticians no longer need hand-holding. For
        example, we use AWS HealthOmics to cut the time to
        complete analysis for cancer research from 1 year to 3
        months. That’s the value that we’re getting right now."

Victor Sankarlingam, senior infrastructure architect at Roche

Missing alt text value

The Children’s Hospital of Philadelphia

        "At Children’s Hospital of Philadelphia, we know that getting
        a comprehensive view of our patients is crucial to delivering
        the best possible care, based on the most innovative
        research. Combining multiple clinical modalities is
        foundational to achieving this. With AWS HealthOmics, we
        can expand our understanding of our patients’ health, all the
        way down to their DNA."

Jeff Pennington, Associate Vice President, Chief Research Informatics Officer, The Children’s Hospital of Philadelphia

Missing alt text value

C2i Genomics

"In C2i Genomics, we empower our data scientists by providing them cloud-based computational solutions to run high-scale, customizable genomic pipelines, allowing them to focus on method development and clinical performance, while the company’s engineering teams are responsible for the operations, security, and privacy aspects of the workloads. AWS HealthOmics allows researchers to use tools and languages from their own domain and considerably reduces the engineering maintenance effort while taking care of cost and resource allocation considerations, which, in turn, reduce time-to-market and NRE costs of new features and algorithmic improvements."

Ury Alon, VP of Engineering, C2i Genomics
Missing alt text value

Ultima Genomics

"Ultima Genomics is unleashing the power of genomics at scale. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. We are excited to work with AWS to help our customers to scale secondary analysis with AWS HealthOmics."

Omer Barad, VP of Genomic Solutions, Ultima Genomics
Missing alt text value

Sentieon

        "At Sentieon, we are dedicated to enabling precision data for
        precision medicine. AWS HealthOmics simplifies the
        infrastructure setup to run Sentieon’s suite of bioinformatics
        secondary analysis tools. We look forward to offering our
        analysis workflows on AWS HealthOmics."

Brendan Gallagher, Head of Business Development, Sentieon

Missing alt text value

BioTeam

BioTeam is a life sciences IT consulting company assionate about accelerating scientific discovery by closing the gap between what scientists want to do with data and what they can do.

        "We look forward to utilizing AWS HealthOmics as one of
        our tools to help simplify automating the collection,
        organization, and transformation of data from large genomic
        sequencing efforts for our clients."

William Van Etten, Co-founder and Senior Scientific Consultant, BioTeam

Missing alt text value

Lifebit

"At Lifebit, we’re on a mission to connect the world’s biomedical data to obtain novel therapeutic insights. Our customers work with vast cohorts of linked genomic, multi-omics and clinical data - and these data volumes are expanding rapidly. With AWS HealthOmics they will have access to optimised analytics and storage for this large-scale data, allowing us to provide even more scalable bioinformatics solutions. Our customers will benefit from significantly lower cost per gigabase of data, essentially achieving hot storage performance at cold storage prices, removing cost as a barrier to generating insights from their population-scale biomedical data."

Thorben Seeger, Chief Business Development Officer, Lifebit
Missing alt text value

Sonrai

"With AWS HealthOmics, we are able to provide biotech and pharma companies with advanced analytics to accelerate drug discovery and cut research study timelines by 70%."

Dr. Matthew Alderdice, Head of Data Science at Sonrai
Missing alt text value